Survivors should be assessed for physical (e.g.: urinary, sexual, bowel) and
psychosocial effects of prostate cancer and its treatment; the focus of assessment should be tailored to the type of cancer treatment
received and current disease state to trigger appropriate self - management and clinical management strategies for
support and therapy.